Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors J Strosberg, G El-Haddad, E Wolin, A Hendifar, J Yao, B Chasen, E Mittra, ... New England Journal of Medicine 376 (2), 125-135, 2017 | 2933 | 2017 |
A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle MF Kircher, A De La Zerda, JV Jokerst, CL Zavaleta, PJ Kempen, E Mittra, ... Nature medicine 18 (5), 829-834, 2012 | 1174 | 2012 |
Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention C Rubin, AS Turner, R Müller, E Mittra, K McLeod, W Lin, YX Qin Journal of bone and mineral research 17 (2), 349-357, 2002 | 450 | 2002 |
US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose–positron emission tomography imaging: Southwest … OW Press, H Li, H Schöder, DJ Straus, CH Moskowitz, M LeBlanc, ... Journal of Clinical Oncology 34 (17), 2020-2027, 2016 | 303 | 2016 |
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long … JR Strosberg, ME Caplin, PL Kunz, PB Ruszniewski, L Bodei, A Hendifar, ... The Lancet Oncology 22 (12), 1752-1763, 2021 | 284 | 2021 |
Clinically approved nanoparticle imaging agents AS Thakor, JV Jokerst, P Ghanouni, JL Campbell, E Mittra, SS Gambhir Journal of Nuclear Medicine 57 (12), 1833-1837, 2016 | 270 | 2016 |
Interrelationship of trabecular mechanical and microstructural properties in sheep trabecular bone E Mittra, C Rubin, YX Qin Journal of biomechanics 38 (6), 1229-1237, 2005 | 245 | 2005 |
Prospective Evaluation of 99mTc MDP Scintigraphy, 18F NaF PET/CT, and 18F FDG PET/CT for Detection of Skeletal Metastases A Iagaru, E Mittra, DW Dick, SS Gambhir Molecular imaging and biology 14, 252-259, 2012 | 171 | 2012 |
Pilot Pharmacokinetic and Dosimetric Studies of 18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3 Integrin Levels ES Mittra, ML Goris, AH Iagaru, A Kardan, L Burton, R Berganos, E Chang, ... Radiology 260 (1), 182-191, 2011 | 153 | 2011 |
Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non … S Baek, CM Choi, SH Ahn, JW Lee, G Gong, JS Ryu, SJ Oh, ... Clinical cancer research 18 (19), 5427-5437, 2012 | 146 | 2012 |
Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study A Iagaru, E Mittra, SS Yaghoubi, DW Dick, A Quon, ML Goris, SS Gambhir Journal of Nuclear Medicine 50 (4), 501-505, 2009 | 126 | 2009 |
Neuroendocrine Tumor Therapy: 177Lu-DOTATATE ES Mittra American Journal of Roentgenology 211 (2), 278-285, 2018 | 111 | 2018 |
NANETS/SNMMI consensus statement on patient selection and appropriate use of 177Lu-DOTATATE peptide receptor radionuclide therapy TA Hope, L Bodei, JA Chan, G El-Haddad, N Fidelman, PL Kunz, ... Journal of Nuclear Medicine 61 (2), 222-227, 2020 | 106 | 2020 |
Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images T Yamamoto, S Kabus, C Lorenz, E Mittra, JC Hong, M Chung, N Eclov, ... International Journal of Radiation Oncology* Biology* Physics 90 (2), 414-422, 2014 | 105 | 2014 |
Evaluation of trabecular mechanical and microstructural properties in human calcaneal bone of advanced age using mechanical testing, μCT, and DXA E Mittra, C Rubin, B Gruber, YX Qin Journal of Biomechanics 41 (2), 368-375, 2008 | 103 | 2008 |
Positron emission tomography/computed tomography: the current technology and applications E Mittra, A Quon Radiologic Clinics of North America 47 (1), 147-160, 2009 | 99 | 2009 |
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study J Strosberg, PL Kunz, A Hendifar, J Yao, D Bushnell, MH Kulke, RP Baum, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 2372-2382, 2020 | 94 | 2020 |
Predicting response to immunotherapy by evaluating tumors, lymphoid cell-rich organs, and immune-related adverse events using FDG-PET/CT T Nobashi, L Baratto, SA Reddy, S Srinivas, A Toriihara, N Hatami, ... Clinical nuclear medicine 44 (4), e272-e279, 2019 | 93 | 2019 |
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin–99mTc-sulfur colloid SPECT MGEH Lam, ML Goris, AH Iagaru, ES Mittra, JD Louie, DY Sze Journal of Nuclear Medicine 54 (12), 2055-2061, 2013 | 92 | 2013 |
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases A Iagaru, P Young, E Mittra, DW Dick, R Herfkens, SS Gambhir Clinical nuclear medicine 38 (7), e290-e296, 2013 | 89 | 2013 |